| Product Code: ETC13129888 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Non-24-Hour Sleep-Wake Disorder Drug Market was valued at USD 0.18 Billion in 2024 and is expected to reach USD 0.28 Billion by 2031, growing at a compound annual growth rate of 6.60% during the forecast period (2025-2031).
The Global Non-24-Hour Sleep-Wake Disorder Drug Market is experiencing steady growth due to the rising prevalence of the disorder, characterized by the body`s inability to synchronize its internal clock with the 24-hour day. The market is driven by increasing awareness, improved diagnosis rates, and a growing elderly population susceptible to this condition. Key players in the market are investing in research and development activities to introduce novel treatment options, such as melatonin receptor agonists, to address the unmet medical needs of patients. Geographically, North America holds a significant share in the market, followed by Europe and Asia-Pacific regions. Overall, the market is poised for expansion as healthcare providers and pharmaceutical companies focus on developing effective therapies to manage Non-24-Hour Sleep-Wake Disorder.
The Global Non-24-Hour Sleep-Wake Disorder Drug Market is witnessing significant growth due to the rising awareness and diagnosis of the disorder among individuals with visual impairment. The market is driven by the increasing research and development efforts to introduce novel treatment options, such as tasimelteon, to address the unmet medical needs of patients. Additionally, the expanding geriatric population and the prevalence of conditions like blindness are contributing to market growth. Opportunities in the market lie in collaborations between pharmaceutical companies and healthcare providers to improve access to treatment, as well as in the development of personalized medicine approaches for more effective management of Non-24-Hour Sleep-Wake Disorder. Overall, the market is poised for continued expansion as advancements in therapeutics and diagnostics drive innovation and improve patient outcomes.
One of the key challenges faced in the Global Non-24-Hour Sleep-Wake Disorder Drug Market is the lack of awareness and understanding of the condition among both healthcare professionals and the general population. Non-24-Hour Sleep-Wake Disorder is a rare circadian rhythm disorder, and its symptoms can often be misinterpreted or overlooked, leading to delays in diagnosis and treatment. Additionally, the limited number of approved drugs specifically targeting this disorder poses a challenge for patients seeking effective treatment options. The market also faces barriers in terms of high treatment costs, reimbursement issues, and the need for more research to develop innovative therapies. Overall, addressing these challenges will require increased education, awareness campaigns, and collaborative efforts among healthcare providers, pharmaceutical companies, and regulatory bodies to improve patient outcomes in the Non-24-Hour Sleep-Wake Disorder market.
The Global Non-24-Hour Sleep-Wake Disorder Drug Market is primarily driven by the increasing prevalence of Non-24-Hour Sleep-Wake Disorder (N24SWD) among blind individuals, as this disorder is most commonly observed in people who are totally blind. Additionally, the rising awareness about N24SWD, advancements in diagnostic techniques, and the development of novel therapies are contributing to the market growth. Moreover, the growing geriatric population, who are more susceptible to sleep disorders, is also fueling the demand for N24SWD drugs. Furthermore, collaborations between pharmaceutical companies and research institutions to innovate new treatment options and the expanding healthcare infrastructure in developing countries are expected to drive the market further.
Government policies related to the Global Non-24-Hour Sleep-Wake Disorder Drug Market primarily focus on regulatory approval processes, patent protection, and pricing regulations. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in evaluating the safety and efficacy of new drugs for Non-24-Hour Sleep-Wake Disorder before granting market authorization. Additionally, governments may implement policies to incentivize research and development in this area through grants or tax breaks. Patent protection is also a key consideration to encourage innovation and investment in developing new treatments for Non-24-Hour Sleep-Wake Disorder. Pricing regulations may vary by country, with some governments implementing measures to ensure affordability and access to these medications for patients in need.
The Global Non-24-Hour Sleep-Wake Disorder Drug Market is expected to witness significant growth in the coming years due to increasing awareness about the condition and rising prevalence of the disorder. Non-24-Hour Sleep-Wake Disorder primarily affects individuals who are blind, disrupting their circadian rhythm and leading to sleep disturbances. The market is likely to be driven by advancements in research and development of novel treatment options, as well as the growing aging population globally. Additionally, the expansion of healthcare infrastructure in developing regions and the availability of effective drugs are anticipated to contribute to market growth. However, challenges such as limited awareness among healthcare professionals and patients, as well as high treatment costs, may hinder market expansion to some extent.
In the Global Non-24-Hour Sleep-Wake Disorder Drug Market, Asia is expected to witness significant growth due to the increasing awareness about the disorder and rising healthcare expenditure in countries like Japan and South Korea. North America is anticipated to dominate the market owing to the high prevalence of Non-24-Hour Sleep-Wake Disorder and the presence of key market players in the region. In Europe, the market is projected to grow steadily due to the rising geriatric population and advancements in healthcare infrastructure. The Middle East and Africa region is likely to experience moderate growth as awareness about the disorder increases. Latin America is also expected to show growth potential with improving healthcare facilities and increasing research and development activities in the region.
Global Non-24-Hour Sleep-Wake Disorder Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.9 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.11 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Global Non-24-Hour Sleep-Wake Disorder Drug Market, 2021 - 2031 |
6.1 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021 - 2031 |
6.1.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Hypernychthemeral Syndrome, 2021 - 2031 |
6.1.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Shift Work Disorder, 2021 - 2031 |
6.1.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Jet Lag and Others, 2021 - 2031 |
6.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Therapeutic Devices, 2021 - 2031 |
6.2.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Nonbenzodiazepines, 2021 - 2031 |
6.3.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Benzodiazepines, 2021 - 2031 |
6.3.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.4.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Home Care Settings, 2021 - 2031 |
6.5.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Wellness Centers and Spa, 2021 - 2031 |
6.5.6 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.6.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drug Stores, 2021 - 2031 |
6.6.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.6.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
7.1 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
7.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.8 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
8.1 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.4 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.5 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8.6 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
8.8 Latin America (LATAM) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
9.1 Asia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.4 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.5 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9.6 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
9.8 Asia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
10.1 Africa Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.4 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.5 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10.6 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
10.8 Africa Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
11.1 Europe Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.4 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.5 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11.6 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
11.8 Europe Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Overview & Analysis |
12.1 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.4 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.5 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12.6 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
12.8 Middle East Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
14 Global Non-24-Hour Sleep-Wake Disorder Drug Market - Export/Import By Countries Assessment |
15 Global Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
15.1 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.3 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.4 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
15.5 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
15.7 Global Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
16.1 Global Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
16.2 Global Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |